![Thomas Jensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Jensen
Fondateur chez
ALLARITY THERAPEUTICS, INC.
Fortune : 841 395 $ au 31/08/2026
Profil
Thomas H.
Jensen is the founder of Allarity Therapeutics A, founded in 2004, serving as Chief Executive Officer & Director since 2023.
Mr. Jensen is the founder of Allarity Therapeutics, Inc., founded in 2004, serving as Chief Executive Officer & Director since 2023.
Mr. Jensen is the founder of Medical Prognosis Institute A, founded in 2006.
Mr. Jensen is the founder of XRGenomics Ltd., founded in 2012.
Mr. Jensen currently holds the position of Director at Cardeon AB. Mr. Jensen currently holds the position of Director at Valion Bio, Inc., starting in 2026.
Mr. Jensen was Chief Technology Officer at Oncology Venture Sweden AB. Mr. Jensen completed undergraduate education at the Technical University of Denmark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/01/2026 | 596 734 ( 3,75 % ) | 841 395 $ | 31/08/2026 |
Postes actifs de Thomas Jensen
| Sociétés | Poste | Début |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Fondateur | 01/01/2004 |
| CARDEON AB | Directeur/Membre du Conseil | - |
| VALION BIO, INC. | Directeur/Membre du Conseil | 27/08/2026 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Fondateur | 01/01/2004 |
Anciens postes connus de Thomas Jensen
| Sociétés | Poste | Fin |
|---|---|---|
Medical Prognosis Institute A/S
 Medical Prognosis Institute A/S BiotechnologyHealth Technology Develops and researches prognostic products towards cancer treatment | Fondateur | - |
XRGenomics Ltd. | Fondateur | - |
Oncology Venture Sweden AB
 Oncology Venture Sweden AB BiotechnologyHealth Technology Provides oncology products | Directeur Technique/Scientifique/R&D | - |
Formation de Thomas Jensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Develops and researches prognostic products towards cancer treatment | Health Technology |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Provides oncology products | Health Technology |
XRGenomics Ltd. | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Health Technology |
Tivic Health Systems, Inc.
 Tivic Health Systems, Inc. Medical SpecialtiesHealth Technology Manufactures bio-electrical sinus medical devices | Health Technology |
Allarity Therapeutics, Inc.
 Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Cardeon AB
 Cardeon AB Financial ConglomeratesFinance Provides investment services | Finance |
